Year None202320222021201920182017 Jan 12, 2023 BioXcel reports data from study of rare prostate cancer therapy Jan 11, 2023 BioXcel, keeping cards close to its chest, teases phase 2 Keytruda combination trial data drop Jan 11, 2023 BioXcel Spinout Posts Promising Results in Rare Prostate Cancer Jan 06, 2023 Genetics, Alzheimer's And AI — Why 2023 Could Be The Year For Biotech Stocks
Jan 11, 2023 BioXcel, keeping cards close to its chest, teases phase 2 Keytruda combination trial data drop